Citations

Clear

64 citation(s) found for "Sathish, Venkatachalem".

Secreted Brain-Derived Neurotrophic Factor and Asthma Severity
Wang, Shengyu , Sathish, Venkatachalem , Freeman, Michelle, Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | February 1, 2016 | Volume: 54 | Issue: 2 | Pages: 297-297

10.1165/rcmb.2015-0265le | PMID 26829500 Get It

Sex Steroids Influence Brain-Derived Neurotropic Factor Secretion From Human Airway Smooth Muscle Cells
Wang, Sheng-Yu, Freeman, Michelle, Sathish, Venkatachalem , Prakash, Y. S. , Freeman, Michelle R, Wang, Sheng-Yu, Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

Mayo Clinic

Journal of Cellular Physiology | November 13, 2015 | Volume: 231 | Issue: 7 | Pages: 1586-1592

10.1002/jcp.25254 | PMID 26566264 Get It

Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma
Yarova, Polina , Stewart, Alecia, Sathish, Venkatachalem , Britt, Rodney D. , Lowe, Alexander P. P. , Freeman, Michelle, Aravamudan, Bharathi, Kita, Hirohito , Brennan, Sarah C. , Schepelmann, Martin , Yung, Sun, Cholisoh, Zakky , Kidd, Emma J. , Rietdorf, Katja , Chang, Wenhan , Khayat, Mohd Ezuan , Ward, Donald T. , Corrigan, Christopher J. , Ward, Jeremy , Prakash, Y. S. , Riccardi, Daniela , Stewart, Alecia L, Thompson, Michael A. , Davies, Thomas , Ford, William R. , Broadley, Kenneth J. , Kemp, Paul J. , Pabelick, Christina M. , Prakash, Y S , Kita, H , Sathish, Venkatachalem

Mayo Clinic

Science Translational Medicine | April 22, 2015 | Volume: 7 | Issue: 284 | Pages: No page available

10.1126/scitranslmed.aaa0282 | PMID 25904744 Get It

Calcilytics reduce airway hyperresponsiveness and inflammation and may represent effective asthma therapeutics.
Brain-Derived Neurotrophic Factor in Cigarette Smoke–Induced Airway Hyperreactivity
Sathish, Venkatachalem , VanOosten, Sarah Kay, Miller, Brent S., Aravamudan, Bharathi, Vassallo, Robert , Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Vassallo, Robert , Sathish, Venkatachalem

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | December 21, 2012 | Volume: 48 | Issue: 4 | Pages: 431-438

10.1165/rcmb.2012-0129oc | PMID 23258230 Get It

Abstract Enhanced airway smooth muscle (ASM) contractility contributes to increased resistance to airflow in diseases such as bronchitis and asthma that occur in passive smokers exposed to secondhand smoke. Little information exists on the cellular mechanisms underlying such airway hyperreactivity. Sputum samples of patients with chronic sinusitis, bronchitis, and asthma show increased concentrations of growth factors called neurotrophins, including brain-derived growth factor (BDNF), but their physiological significance remains unknown. In human ASM, we tested the hypothesis that BDNF contributes to increased contractility with cigarette smoke exposure. The exposure of ASM to 1% or 2% cigarette smoke extract (CSE) for 24 hours increased intracellular calcium ([Ca2+]i) responses to histamine, and further potentiated the enhancing effects of a range of BDNF concentrations on such histamine responses. CSE exposure increased the expression of the both high-affinity and low-affinity neurotrophin receptors tropomyosin-related kinase (Trk)–B and p75 pan-neurotrophin receptor, respectively. Quantitative ELISA showed that CSE increased BDNF secretion by human ASM cells. BDNF small interfering (si)RNA and/or the chelation of extracellular BDNF, using TrkB-fragment crystallizable, blunted the effects of CSE on [Ca2+]i responses as well as the CSE enhancement of cell proliferation, whereas TrkB siRNA blunted the effects of CSE on ASM contractility. These data suggest that cigarette smoke is a potent inducer of BDNF and TrkB expression and signaling in ASM, which then contribute to cigarette smoke–induced airway hyperresponsiveness.
Faculty Opinions recommendation of Interaction of hydrogen sulfide and estrogen on the proliferation of vascular smooth muscle cells.
Prakash, Y. S. , Sathish, Venkatachalem

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 14, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717965156.793466277 Get It

Estrogen effects on human airway smooth muscle involve cAMP and protein kinase A
Townsend, Elizabeth , Sathish, Venkatachalem , Prakash, Y. S. , Townsend, Elizabeth , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | September 22, 2012 | Volume: 303 | Issue: 10 | Pages: L923-L928

10.1152/ajplung.00023.2012 | PMID 23002077 Get It

Clinically observed differences in airway reactivity and asthma exacerbations in women at different life stages suggest a role for sex steroids in modulating airway function although their targets and mechanisms of action are still being explored. We have previously shown that clinically relevant concentrations of exogenous estrogen acutely decrease intracellular calcium ([Ca2+]i) in human airway smooth muscle (ASM), thereby facilitating bronchodilation. In this study, we hypothesized that estrogens modulate cyclic nucleotide regulation, resulting in decreased [Ca2+]iin human ASM. In Fura-2-loaded human ASM cells, 1 nM 17β-estradiol (E2) potentiated the inhibitory effect of the β-adrenoceptor (β-AR) agonist isoproterenol (ISO; 100 nM) on histamine-mediated Ca2+entry. Inhibition of protein kinase A (PKA) activity (KT5720; 100 nM) attenuated E2effects on [Ca2+]i. Acute treatment with E2increased cAMP levels in ASM cells comparable to that of ISO (100 pM). In acetylcholine-contracted airways from female guinea pigs or female humans, E2potentiated ISO-induced relaxation. These novel data suggest that, in human ASM, physiologically relevant concentrations of estrogens act via estrogen receptors (ERs) and the cAMP pathway to nongenomically reduce [Ca2+]i, thus promoting bronchodilation. Activation of ERs may be a novel adjunct therapeutic avenue in reactive airway diseases in combination with established cAMP-activating therapies such as β2-agonists.
Oxygen dose responsiveness of human fetal airway smooth muscle cells
Hartman, William R. , Smelter, Dan F. , Sathish, Venkatachalem , Karass, Michael , Kim, Sunchin, Aravamudan, Bharathi, Amrani, Yassine , Pandya, Hitesh , Martin, Richard J. , Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 24, 2012 | Volume: 303 | Issue: 8 | Pages: L711-L719

10.1152/ajplung.00037.2012 | PMID 22923637 Get It

Maintenance of blood oxygen saturation dictates supplemental oxygen administration to premature infants, but hyperoxia predisposes survivors to respiratory diseases such as asthma. Although much research has focused on oxygen effects on alveoli in the setting of bronchopulmonary dysplasia, the mechanisms by which oxygen affects airway structure or function relevant to asthma are still under investigation. We used isolated human fetal airway smooth muscle (fASM) cells from 18–20 postconceptual age lungs (canalicular stage) to examine oxygen effects on intracellular Ca 2+ ([Ca 2+ ] i ) and cellular proliferation. fASM cells expressed substantial smooth muscle actin and myosin and several Ca 2+ regulatory proteins but not fibroblast or epithelial markers, profiles qualitatively comparable to adult human ASM. Fluorescence Ca 2+ imaging showed robust [Ca 2+ ] i responses to 1 μM acetylcholine (ACh) and 10 μM histamine (albeit smaller and slower than adult ASM), partly sensitive to zero extracellular Ca 2+ . Compared with adult, fASM showed greater baseline proliferation. Based on this validation, we assessed fASM responses to 10% hypoxia through 90% hyperoxia and found enhanced proliferation at <60% oxygen but increased apoptosis at >60%, effects accompanied by appropriate changes in proliferative vs. apoptotic markers and enhanced mitochondrial fission at >60% oxygen. [Ca 2+ ] i responses to ACh were enhanced for <60% but blunted at >60% oxygen. These results suggest that hyperoxia has dose-dependent effects on structure and function of developing ASM, which could have consequences for airway diseases of childhood. Thus detrimental effects on ASM should be an additional consideration in assessing risks of supplemental oxygen in prematurity.
Faculty Opinions recommendation of Vitamin D deficiency causes deficits in lung function and alters lung structure.
Venkatachalem, Sathish, Prakash, Y. S.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 20, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.10952957.11888055 Get It

Faculty Opinions recommendation of β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids.
Venkatachalem, Sathish, Prakash, Y. S.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 1, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.13408991.14779105 Get It

Faculty Opinions recommendation of Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma.
Venkatachalem, Sathish, Prakash, Y. S.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 31, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.716947860.792352830 Get It